Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

hypoglycemic treatment

Phase 2Small molecule

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Neurovascular CouplingNot yet recruiting

Neurovascular CouplingPhase 2

Not yet recruiting

Timeline

Expected Milestones

Q4 2026

Phase 2Not yet recruiting

Neurovascular Coupling

NCT06813274

Clinical

Trials by Indication[1]

Neurovascular Coupling1 trial

Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling

Not yet recruiting·HHejiang Ye·Phase 2·NCT06813274·160 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for hypoglycemic treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — hypoglycemic treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for hypoglycemic treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hejiang Ye company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: HHejiang Ye

Related News